Prevention and treatment of anemia in reproductive-aged women with gynecological diseases


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The paper is devoted to a detailed description of the problems of anemia and iron deficiency (ID) in Russia and worldwide; it outlines the epidemiology of these conditions, gives the definitions of anemia and ID, and depicts disease stages. The clinical presentations and impact of anemia on the lives of reproductive-aged women are described in detail. Much attention is paid to the diagnosis and differential diagnosis of ID-associated anemia; various iron deficiency syndromes encountered in gynecology are depicted extensively. The description of a survey of 132 patients with various benign gynecological diseases presents the authors’ own data from a study of the frequency, characteristics, and pathogenesis of anemia in gynecological diseases. It is concluded that pathological blood loss is only one of the factors for anemia. Particular emphasis is placed on the study of hepcidin and the adequacy of production of endogenous erythropoietin, which has led to the conclusion that anemias are mixed in this category of patients and have signs of both iron deficiency anemia (IDA) and anemia of chronic disease. The recommendations of the World Health Organization (WHO) and the Russian Federation are given to prevent and treat anemia and ID. The authors describe the good effect of oral iron preparations in treating anemia in gynecological diseases, but emphasize that uterine fibroids are a factor that worsens a treatment response. The paper discusses the tolerability of oral iron therapy and recommendations for the most effective and safe treatment of IDA.

Full Text

Restricted Access

About the authors

Nikolay I. Stuklov

Peoples' Friendship University of Russia; National Medical Research Center of Radiology

Email: stukJovn@gmail.com

Sergey A. Levakov

I.M. Sechenov First Moscow State Medical University (Sechenov University)

Email: levakoff@yandex.ru

Tatyana V. Sushinskaya

National Medical Research Center of Radiology

Email: talgi65@yandex.ru

Anna A. Mitchenkova

Peoples' Friendship University of Russia

Email: enmitchell07@gmail.com

Maxim S. Kovalchuk

Peoples' Friendship University of Russia

Email: hdcx93@gmail.com

References

  1. World Health Organization. The World Health Report 2002: Reducing risks, promoting healthy life. Geneva: WHO; 2002.
  2. World Health Organization. Iron deficiency anaemia: assessment, prevention, and control. A guide for programme managers. Geneva: WHO; 2001. (WHO/ NHD/01.3).
  3. World Health Organization. The global prevalence of anaemia in 2011. Geneva: WHO; 2015.
  4. DeMaeyer E., Adiels-Tegman M. The prevalence of anaemia in the world. World Health Stat. Q. 1985; 38(3): 302-16.
  5. World Health Organization. The prevalence of anaemia in women: a tabulation of available information. 1992. (WHO/MCH/MSM/92.2).
  6. Worldwide Prevalence of Anaemia 1993-2005: WHO global database on anaemia. Geneva: WHO; 2008.
  7. Zacharski L.R. Association of age, sex and race with body iron stores in adults: analysis of NHANES III data. Am. Heart J. 2000; 140(1): 98-104. https:// dx.doi.org/10.1067/mhj.2000.106646.
  8. Pizarro F., Yip R., Dallman P.R., Olivares M., Hertrampf E., Walter T. Iron status with different infant regimens: relevance to screening and prevention of iron deficiency. J. Pediatr. 1991; 118(5): 687-92. https://dx.doi.org/10.1016/s0022-3476(05)80027-7.
  9. Beard J.L. Iron requirements in adolescent females. J. Nutr. 2000; 130(2, Suppl.): 440S-2S. https://dx.doi.org/10.1093/jn/130.2.440S.
  10. Food and Agriculture Organization of the United Nation, WHO. Human vitamin and mineral requirements. Report of a joint FAO/WHO expert consultation Bangkok, Tailand. Rome, Italy; 2002.
  11. Fairweather-Tait S. Iron requirements and prevalence of iron deficiency in adolescents. An overview. In: Hallberg L., Asp N.G., eds. Iron nutrition in heath and disease. London: Libbey and Co; 1996: 137-48.
  12. DeMaeyer Е.М., Dallman P., Gurney J.M., Hallberg L., Sood S.K., Srikantia S.G. Preventing and controlling iron deficiency anaemia through primary health care. А. guide for health administrators and prograммe мanagers. Geneva: WHO; 1989. https://dx.doi.org/10.1177/156482658901100407.
  13. Aggett PJ. Iron. In: Erdman J.W., Macdonald I.A., Zeisel S.H., eds. Present knowledge in nutrition. 10th ed. Washington, DC: Wiley-Blackwell; 2012: 506-20.
  14. Стуклов Н.И., Алпидовский В.К., Огурцов П.П. Анемии. Клиника, диагностика и лечение. Пособие для врачей. М.: МИА; 2013: 264 с.
  15. Hofbrand A.V., Moss P.A.N. Essential haematology, 6th ed. Oxford, UK Blackwell Publishing; 2011. 454p.
  16. WHO Guidelines Approved by the Guidelines Review Committee. Guideline: daily iron and folic acid supplementation in pregnant women. Geneva: WHO; 2012.
  17. Thurnham D.I., McCabe L.D., Haidar S., Wieringa F.T., Northrop-Clewes C.A., McCabe G.P. Adjusting plasma ferritin concentrations to remove the effects of subclinical inflammation in the assessment of iron deficiency: a metaanalysis. Am. J. Clin. Nutr. 2010; 92 (3): 546-55. https://dx.doi.org/10.3945/ ajcn.2010.29284.
  18. Fleming R.E. Iron and inflammation: cross talk between pathways regulating hepcidin. J. Mol. Med. (Berl.). 2008; 86(5): 491-4. https://dx.doi.org/10.1007/ s00109-008-0349-8.
  19. Dallalio G., Law E., Means R.T. Jr. Hepcidin inhibits in vitro erythroid colony formation at reduced erythropoietin concentrations. Blood. 2006; 107(7): 2702 4. https://dx.doi.org/10.1182/blood-2005-07-2854
  20. Bohlius J., Wilson J., Seidenfeld J., Piper M., Schwarzer G., Sandercock J. et al. Recombinant human erythropoietins and cancer patients: Updated metaanalysis of 57 studies including 9353 patients. J. Natl. Cancer Inst. 2006; 98(10): 708-14. https://dx.doi.org/10.1093/jnci/djj189.
  21. Бурлев В.А., Коноводова Е.Н. Синдром неадекватной продукции эритро-поэтина у больных с миомой матки. Проблемы репродукции. 204; 10(3): 27-33.
  22. Centers for Disease Control and Prevention (CDC). Recommendations to prevent and control iron deficiency in the United States. MMWR Recomm Rep. 1998; 47(RR-3): 1-29.
  23. Murray-Kolbe L.E., Beard J. Iron. In: Coates P.M., Betz J.M., Blackman M.R., Cragg G.M., Levine M., Moss J., White J.D., eds. Encyclopedia of dietary supplements. 2nd ed. London, New York: Informa Healthcare; 2010: 432-8.
  24. Bailey R.L., Gahche J.J., Lentino C.V., Dwyer J.T., Engel J.S., Thomas PR. et al. Dietary supplement use in the United States, 2003-2006. J. Nutr. 2011; 141(2): 261-6. https://dx.doi.org/10.3945/jn.110.133025.
  25. Cogswell M.E., Kettel-Khan L., Ramakrishnan U. Iron supplement use among women in the United States: science, policy and practice. J. Nutr. 2003; 133(6): 1974S-7S. https://dx.doi.org/10.1093/jn/133.6.1974S.
  26. World Health Organization. Guideline: Daily iron supplementation in adult women and adolescent girls. Geneva: WHO; 2016.
  27. Thurlow R.A., Winichagoon P., Green T., Wasantwisut E., Pongcharoen T., Bailey K.B., Gibson R.S. Only a small proportion of anemia in northeast Thai schoolchildren is associated with iron deficiency. Am. J. Clin. Nutr. 2005; 82(2): 380-7. https://dx.doi.org/10.1093/ajcn.82.2.380.
  28. Gillespie S.R., Kevany J., Mason J.B. Controlling iron deficiency. Administrative committee on coordination/subcommittee on nutrition state-of-the-art series. Geneva: UN Standing Committee on Nutrition; 1991. (Nutrition Policy Discussion Paper No. 9.)
  29. World Health Organization. Guideline: Intermittent iron and folic acid supplementation in menstruating women. Geneva: WHO; 2016.
  30. Nguyen P., Grajeda R., Melgar P., Marcinkevage J., Flores R., Martorell R. Weekly may be as efficacious as daily folic acid supplementation in improving folate status and lowering serum homocysteine concentrations in Guatemalan women. J. Nutr. 2008; 138(8): 1491-8. https://dx.doi.org/10.1093/jn/138.8.1491.
  31. Коноводова Е.Н., Серов В.Н., Бурлев В.А., Кан Н.Е., Тютюнник В.Л. Федеральный клинический протокол. Диагностика, профилактика и лечение железодефицитных состояний у беременных и родильниц. М.: Российское общество акушеров-гинекологов, ФГБУ «Научный Центр акушерства, гинекологии и перинатологии им. В.И.Кулакова» Минздрава России; 2013.
  32. Liumbruno G., Bennardello F., Lattanzio A., Piccoli P., Rossetti G. Recommendations for the transfusion of red blood cells. Blood Transfus. 2009; 7(1): 49-64. https://dx.doi.org/10.2450/2008.0020-08.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2020 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies